Furthermore, there is a growing amount of evidence suggesting that inhibiting IL-1B production or activation of its’ receptor, IL-1R1, maybe effective therapeutic strategies for preventing/treating breast cancer bone metastasis [3], [4], [5], [6], [7], [8], [9]. Here, IL1B is linked to breast carcinoma.